EU advises against AstraZeneca shot in people with rare blood condition

Europe's drug regulator on Friday advised against using AstraZeneca's COVID-19 vaccine in people with a history of a rare bleeding condition and said it was looking into heart inflammation cases after inoculation with all coronavirus shots.

The European Medicines Agency's (EMA) safety committee in its evaluation said that capillary leak syndrome must be added as a new side effect to labelling on AstraZeneca's vaccine. It is a condition in which blood leaks from the smallest of vessels into muscles and body cavities and is characterised by swelling and a drop in blood pressure.